In our series of workshops and trainings from members to members we hosted yesterday a workshop regarding “Compliance” with a focus on small and medium biotech companies. Olga Kaus, Head of compliance at Affimed guided us through this complex topic and was able to depict the implementation of a compliance system as an opportunity for business growth rather than an impediment.
Affimed’s mission is to create novel therapeutic options for patients suffering from cancer and other life-threatening diseases. A number of clinical and preclinical programs are in development based on the ROCK® platform and tetravalent bispecific immune cell engagers have already shown a favorable safety profile and promising signs of therapeutic efficacy.
BioRN, the Life Science Cluster Rhine-Neckar gives voice to its members through different event formats. Beyond the BioRN Lounges and Annual Conference, BioRN recently initiated a series of thematic workshops, offering specialized training for a range of topics, skills and techniques on one side. On the other side, members organising the workshop can easily reach their target audience.
After presenting some practical examples of corruption and fraud, that could have been probably prevented by simple compliance implementation, Olga Kaus guided the audience through the compliance life cycle.
Based on the experience at Affimed, Olga Kaus finally presented concrete required actions and tools to be implemented, processes to be established, evaluated and adopted accordingly to the development of the company itself, in order to build and maintain a robust business.
BioRN is the science and industry cluster of the Rhine/Main/Neckar region around Heidelberg, one of Germany’s strongest biotech hubs. It is a non-profit network fostering health innovations and serving its members by creating a rich translational ecosystem as well as promoting, representing and connecting the regional innovation stakeholders.
Our vision is to develop the region into a world-leading life science cluster attracting international investments and top global talent.
BioRN has more than 100 institutional members, including the top academic and research institutions, 7 global health care companies, a large range of small and medium-sized enterprises bolstering the life science ecosystem as well as local government organizations and interest groups.